Comment by ops4c0d3

For those willing (or those with power of attorney), would nanoparticle research experiments be worth the wont, per OP's point? While two major drug trials are being dropped towards the amyloid target (based on aducanumab) on public display, why not look towards AI and neuroplasticity measures to find the next set of targets